Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 10 recruiting now full pipeline

Tobacco Dependence: full-pipeline trial registry

10 of 29 indexed Tobacco Dependence trials are currently recruiting.

Corpus placement: #552 of 28,707 conditions by registered trial count.

29 US clinical trials · 10 currently recruiting · #552 of 28,707 conditions by registered trial count

Tobacco Dependence: 29 US clinical trials tracked, 10 recruiting.

Tobacco Dependence is the subject of 29 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 4 of these trials.

Enrollment posture brief

Registry condition tobacco-dependence

OPEN 10 | RECR 34% | LATE 6 | EARLY 5 | RANK #552 | SPON 4

Nearest open-share peer: Colitis, Ulcerative (34% recruiting · 29 trials)

Advanced Breast Cancer62.1%Amyloidosis51.7%Tobacco Dependence (this)34%Arthritis, Rheumatoid17.2%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Tobacco Dependence

Tobacco Dependence lists 10 open slots (34% of 29 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tobacco Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tobacco Dependence is recruiting below its size-band peers.

    10 of 29 indexed trials (34.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Tobacco Dependence trials is spread across many organizations.

    Johns Hopkins University accounts for 4 of 29 trials (13.8%). 21 distinct sponsors appear on at least one study for this condition label.

  3. Typical Tobacco Dependence enrolment sits around 240 participants.

    Median target enrolment is 240 among the 29 trials that report a genuine target (sentinel values excluded). 6 of those (20.7%) plan for fewer than 100 participants.

  4. Tobacco Dependence research is mostly interventional.

    29 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 24Phase 31Phase 45

Open and recent trials

29 total, page 1 of 1

RECRUITING NA 1,560 participants

Reach Through Equitable Implementation in Utah

University of Utah

NCT06881069

RECRUITING NA 544 participants

Smoke-free Home Study in Subsidized Housing

University of California, San Francisco

NCT06170437

RECRUITING NA 540 participants

FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers

University of Arkansas

NCT05429892

RECRUITING Phase 3 400 participants

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

University of Alabama at Birmingham

NCT03912194

RECRUITING NA 375 participants

Use of Nicotine Pouches Among Daily Smokers

Milton S. Hershey Medical Center

NCT06043362

RECRUITING NA 250 participants

Harm Reduction for Smokers With Mental Illness

Dartmouth-Hitchcock Medical Center

NCT06543407

RECRUITING Phase 4 150 participants

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

University of California, San Francisco

NCT07148232

RECRUITING Phase 2 120 participants

Cannabidiol for Reducing Cigarette Use

University of California, Los Angeles

NCT06218056

RECRUITING Phase 1 50 participants

Oral Cannabidiol for Tobacco Cessation

Johns Hopkins University

NCT05445804

RECRUITING Phase 4 30 participants

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Johns Hopkins University

NCT07220356

ACTIVE NOT RECRUITING NA 865 participants

Assessment of Biomarkers in Children to Help Parents Quit Tobacco

Massachusetts General Hospital

NCT04832659

COMPLETED Phase 2 2,711 participants

Provider and Peer Delivered Youth Smoking Intervention

University of Massachusetts, Worcester

NCT00435344

COMPLETED NA 1,944 participants

Helping Poor Smokers Quit

Washington University School of Medicine

NCT03194958

COMPLETED NA 956 participants

Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry

Stanford University

NCT00968513

COMPLETED Phase 4 463 participants

Bupropion SR Plus Counseling for Smoking Cessation

University of Wisconsin, Madison

NCT01621009

COMPLETED NA 444 participants

System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS

The Miriam Hospital

NCT01839903

COMPLETED NA 360 participants

Tobacco Treatment for Employable Californians, Total IMPACT Study

Stanford University

NCT02478697

COMPLETED Phase 4 313 participants

Varenicline OTC Trial on Efficacy and Safety

Arizona State University

NCT03557294

COMPLETED NA 240 participants

The Appeal and Impact of E-cigarettes in Smokers With SMI

Dartmouth-Hitchcock Medical Center

NCT03050853

COMPLETED NA 165 participants

A Facebook Intervention for Young Sexual and Gender Minority Smokers

University of California, San Francisco

NCT03259360

COMPLETED NA 163 participants

Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement

H. Lee Moffitt Cancer Center and Research Institute

NCT00747643

COMPLETED NA 158 participants

Innovative Digital Therapeutic for Smoking Cessation

My Digital Study

NCT03694327

COMPLETED Phase 2 150 participants

S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence

Mayo Clinic

NCT00722124

COMPLETED NA 109 participants

Tobacco Dependence Treatment for Asian Americans

University of Massachusetts, Boston

NCT01091363

COMPLETED NA 100 participants

A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

Johns Hopkins University

NCT01334736

COMPLETED NA 95 participants

Personalized Feedback for Smokers With Elevated Anxiety Sensitivity

University of Houston

NCT03382093

COMPLETED NA 79 participants

Effects of Yoga and Cardiovascular Exercise on Smoking Motivation

H. Lee Moffitt Cancer Center and Research Institute

NCT01423578

COMPLETED Phase 2 58 participants

Very Low Nicotine Cigarettes in Smokers With Schizophrenia

Brown University

NCT02019459

COMPLETED Phase 4 10 participants

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

Johns Hopkins University

NCT06545669

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 4
Phase 3 1
Phase 4 5

Named interventions

Most-linked intervention names on Tobacco Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Lung Cancer Screening Other
2 trials
C-Raven Virtual Tobacco Cessation Counseling Behavioral
2 trials
Nicotine Replacement Product Drug
2 trials
Community Health Worker Other
2 trials
Placebo Drug
2 trials
Cardiovascular Exercise (CE) Behavioral
1 trials
Hatha Yoga (HY) Behavioral
1 trials
standard nicotine content cigarettes Other
1 trials

US sites by state

Facility locations filed on Tobacco Dependence trials. A trial with sites in several states counts in each.

California 7 trials
Maryland 4 trials
Massachusetts 4 trials
Rhode Island 3 trials
Wisconsin 2 trials
Texas 2 trials
Kentucky 2 trials
Florida 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tobacco Dependence page

29 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tobacco Dependence condition card totals 29 registered trials; most-linked intervention Lung Cancer Screening; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.